首页>Expert review of anticancer therapy>Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?
Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?
作者单位:Department of Radiation Oncology Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA[1]Department of Radiation Oncology, Kimmel Cancer Center, Jefferson Medical College of Thomas[2]